Skip to Main Content

Paper Details

Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A <i>post hoc</i> Analysis from the Randomized VERTIS CV Trial.
Kidney Int Rep
4
2022
Author NameAffiliation
David Z I CherneyUniversity of Toronto
Christopher P CannonBrigham and Women's Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2